Scientists from US and Australia found that cannabidiol has excellent activity against biofilms, little propensity to induce resistance, and topical in vivo efficacy. CBD had remarkably useful antimicrobial activity with potential clinical utility for nasal decolonization.

Blaskovich, M., Kavanagh, A. M., Elliott, A. G., Zhang, B., Ramu, S., Amado, M., Lowe, G. J., Hinton, A. O., Pham, D., Zuegg, J., Beare, N., Quach, D., Sharp, M. D., Pogliano, J., Rogers, A. P., Lyras, D., Tan, L., West, N. P., Crawford, D. W., Peterson, M. L., … Thurn, M. (2021). The antimicrobial potential of cannabidiol. Communications biology, 4(1), 7. https://doi.org/10.1038/s42003-020-01530-y

Antimicrobial resistance threatens the viability of modern medicine, which is largely dependent on the successful prevention and treatment of bacterial infections.

Using cannabidiol could be helpful to fight against strains of bacteria, viruses, parasites and fungi that are resistant to most of the antibiotics and other medications commonly used to treat the infections they cause.

Not only cannabidiol can stop superbugs, but also it can stop COVID-19 by disabling SARS-CoV-2 replication! #LegalizeIt #MedicalCannabis